Dylan Birchard

927 total citations · 1 hit paper
12 papers, 491 citations indexed

About

Dylan Birchard is a scholar working on Immunology, Physiology and Surgery. According to data from OpenAlex, Dylan Birchard has authored 12 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Physiology and 6 papers in Surgery. Recurrent topics in Dylan Birchard's work include IL-33, ST2, and ILC Pathways (10 papers), Asthma and respiratory diseases (8 papers) and Eosinophilic Esophagitis (6 papers). Dylan Birchard is often cited by papers focused on IL-33, ST2, and ILC Pathways (10 papers), Asthma and respiratory diseases (8 papers) and Eosinophilic Esophagitis (6 papers). Dylan Birchard collaborates with scholars based in United States and Sweden. Dylan Birchard's co-authors include George Scott, Jamie Orengo, Matthew A. Sleeman, Andrew Murphy, Jeanne Allinne, Wei Keat Lim, George D. Yancopoulos, Tammy Huang, Neil Stahl and Seblewongel Asrat and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Cytokine.

In The Last Decade

Dylan Birchard

10 papers receiving 482 citations

Hit Papers

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dylan Birchard United States 5 300 181 172 120 100 12 491
Jeanne Allinne United States 5 295 1.0× 180 1.0× 170 1.0× 120 1.0× 99 1.0× 12 487
Joanna Glück Poland 10 197 0.7× 110 0.6× 131 0.8× 66 0.6× 68 0.7× 51 328
Emanuele Nappi Italy 10 204 0.7× 98 0.5× 97 0.6× 15 0.1× 101 1.0× 25 383
Denise Garofalo United States 6 271 0.9× 78 0.4× 202 1.2× 9 0.1× 79 0.8× 12 377
Luo Ba China 10 193 0.6× 187 1.0× 39 0.2× 16 0.1× 92 0.9× 20 412
K. Botturi France 8 133 0.4× 85 0.5× 61 0.4× 39 0.3× 39 0.4× 13 326
John Eckman United States 9 110 0.4× 226 1.2× 120 0.7× 65 0.5× 42 0.4× 15 472
Hannah H. Walford United States 4 128 0.4× 43 0.2× 161 0.9× 8 0.1× 197 2.0× 5 382
S Kubo Japan 11 170 0.6× 210 1.2× 45 0.3× 86 0.7× 53 0.5× 22 344
Matt Edwards United Kingdom 2 238 0.8× 32 0.2× 186 1.1× 19 0.2× 72 0.7× 5 403

Countries citing papers authored by Dylan Birchard

Since Specialization
Citations

This map shows the geographic impact of Dylan Birchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan Birchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan Birchard more than expected).

Fields of papers citing papers by Dylan Birchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dylan Birchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan Birchard. The network helps show where Dylan Birchard may publish in the future.

Co-authorship network of co-authors of Dylan Birchard

This figure shows the co-authorship network connecting the top 25 collaborators of Dylan Birchard. A scholar is included among the top collaborators of Dylan Birchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dylan Birchard. Dylan Birchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Srivatsan, Subhashini, Seblewongel Asrat, Kirsten Nagashima, et al.. (2023). Interleukin-33 (IL-33) Drives Type 1 and Type 2 Inflammation and Instructs Airway Remodeling. A4473–A4473.
3.
Scott, George, Seblewongel Asrat, Jeanne Allinne, et al.. (2022). IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline. Cytokine. 162. 156091–156091. 54 indexed citations
4.
Nagashima, Kirsten, George Scott, Dylan Birchard, et al.. (2020). Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. Journal of Allergy and Clinical Immunology. 145(2). AB158–AB158. 5 indexed citations
5.
Allinne, Jeanne, George Scott, Wei Keat Lim, et al.. (2019). IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation. Journal of Allergy and Clinical Immunology. 144(6). 1624–1637.e10. 87 indexed citations
6.
Floc’h, Audrey Le, Jeanne Allinne, Kirsten Nagashima, et al.. (2019). Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation. Allergy. 75(5). 1188–1204. 330 indexed citations breakdown →
7.
Allinne, Jeanne, George Scott, Dylan Birchard, et al.. (2019). Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation. PA3877–PA3877. 2 indexed citations
9.
Floc’h, Audrey Le, Jeanne Allinne, Kirsten Nagashima, et al.. (2019). Il-4 and IL-13 act independently and synergistically to drive type 2 inflammation. PA5206–PA5206. 1 indexed citations
10.
Allinne, Jeanne, Wei Keat Lim, George Scott, et al.. (2019). IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling. PA3876–PA3876. 1 indexed citations
11.
Orengo, Jamie, Jeanne Allinne, Audrey Le Floc’h, et al.. (2018). Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model. PA977–PA977. 4 indexed citations
12.
Allinne, Jeanne, George Scott, Dylan Birchard, et al.. (2018). IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.. OA1944–OA1944. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026